Masaru Goto

Masaru Goto

Auto-generated profile, based on publicly available information

Masaru Goto

Faculty of Science Toho University Funabashi Chiba Japan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2007 in Biochemistry
Verified
Journal Article
Closed access
RORie Omi
Rie Omi
MGMasaru Goto
Masaru Goto
IMIkuko Miyahara
Ikuko Miyahara
MMMiho Manzoku
Miho Manzoku
AEAkio Ebihara
Akio Ebihara
KHKen Hirotsu
Ken Hirotsu

23 October 2020 in Acta Crystallographica Section F Structural Biology Communications
Verified
Journal Article
Closed access
PDF file
YSYuya Shimekake
Yuya Shimekake
YHYuki Hirato
Yuki Hirato
RFRikako Funabashi
Rikako Funabashi
SOSayoko Okazaki
Sayoko Okazaki
MGMasaru Goto
Masaru Goto
STShouji Takahashi
Shouji Takahashi

15 July 2015 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
YTYoshihisa Tomonaga
Yoshihisa Tomonaga
RKRyosuke Kaneko
Ryosuke Kaneko
MGMasaru Goto
Masaru Goto
TOToshihisa Ohshima
Toshihisa Ohshima
KYKazuaki Yoshimune
Kazuaki Yoshimune
Homoserine dehydrogenase (HSD; 305 amino acid residues) catalyzes an NAD(P)-dependent reversible reaction between l-homoserine and aspartate 4-semialdehyde and is involved in the aspartate pathway. HSD from the hyperthermophilic archaeon Sulfolobus tokodaii was markedly activated (2.5-fold) by the addition of 0.8 mM dithiothreitol. The crystal structure of the homodimer indicated that the activation was caused by cleavage of the disulfide bond formed between two cysteine residues (C303) in the C-terminal regions of the two subunits.

1 September 2020 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
TITomokazu Ito
Tomokazu Ito
MMMai Matsuoka
Mai Matsuoka
MGMasaru Goto
Masaru Goto
SWSoichiro Watanabe
Soichiro Watanabe
TMTaichi Mizobuchi
Taichi Mizobuchi
TYTohru Yoshimura
Tohru Yoshimura

1 June 2023 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
MGMasaru Goto
Masaru Goto
NSNatsumi Sakamoto
Natsumi Sakamoto
SHShoko Higashi
Shoko Higashi
RKRena Kawata
Rena Kawata
KNKazuki Nagatsu
Kazuki Nagatsu
RSRyota Saito
Ryota Saito
Ricin toxin A chain (RTA), from Ricinus communis, is a deadly protein that inactivates ribosomes by degrading an adenine residue at position 4324 in 28S rRNA. Recently, we have demonstrated that pterin-7-carboxamides with peptide pendants were potent RTA inhibitors. Among these, N-(pterin-7-carbonyl)glycyl-L-tyrosine (7PCGY) is the most potent RTA inhibitor as a small organic molecule. However, despite this fascinating inhibitory activity, the mode of interaction of 7PCGY with RTA remains elusive. This study aimed to elucidate the factors responsible for the high RTA inhibitory activity of 7PCGY based on X-ray crystallographic analysis. Herein, we report the successfully resolved X-ray crystal structure of 7PCGY/RTA complexes, revealing that the interaction between the phenolic hydroxy group in 7PCGY and Asn78 of RTA through a hydrogen bonding and the conformational change of Tyr80 and Asn122 are responsible for the high RTA inhibitory activity of 7PCGY.

31 October 2015 in The Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
STShouji Takahashi
Shouji Takahashi
KSKozue Shimada
Kozue Shimada
SNShunsuke Nozawa
Shunsuke Nozawa
MGMasaru Goto
Masaru Goto
KAKatsumasa Abe
Katsumasa Abe
YKYoshio Kera
Yoshio Kera
D -Aspartate oxidase (DDO) catalyzes the oxidative deamination of acidic d -amino acids, whereas neutral and basic d -amino acids are substrates of d -amino acid oxidase (DAO). DDO of the yeast Cryptococcus humicola (ChDDO) has much higher substrate specificity to d -aspartate, but the structural features that confer this specificity have not been elucidated. A three-dimensional model of ChDDO suggested that a histidine residue (His56) in the active site might be involved in the unique substrate specificity, possibly through the interaction with the substrate side chain in the active site. His56 mutants with several different amino acid residues (H56A, H56D, H56F, H56K and H56N) exhibited no significant activity toward acidic d -amino acids, but H56A and H56N mutants gained the ability to utilize neutral d -amino acids as substrates, such as d -methionine, d -phenylalanine and d -glutamine, showing the conversion of ChDDO to DAO by these mutations. This conversion was also demonstrated by the sensitivity of these mutants to competitive inhibitors of DAO. These results and kinetic properties of the mutants show that His56 is involved in the substrate specificity of ChDDO and possibly plays a role in the higher substrate specificity toward d -aspartate.